Kerendia®▼(finerenone) Patient Support Materials
Useful, downloadable resources for patients initiated on Kerendia®(finerenone)

Kerendia is indicated for the treatment of symptomatic chronic heart failure with left ventricular ejection fraction (LVEF) ≥ 40% in adults.
Kerendia is indicated for the treatment of chronic kidney disease (Stages 3 and 4 with albuminuria) associated with type 2 diabetes in adult patients.
Prescribing information for Kerendia can be found here.
Patient Booklets for Kerendia® (finerenone)
Digital leaflets for you to download and give to your patients who have been prescribed Kerendia. Please always ensure the patient reads the patient information leaflet (PIL) included in the Kerendia box for full details.
Abbreviations
LVEF - Left Ventricular Ejection Fraction
PP-KER-GB-0987 | June 2026